Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy

被引:78
|
作者
Chang, SM [1 ]
Nagueh, SF [1 ]
Spencer, WH [1 ]
Lakkis, NM [1 ]
机构
[1] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
关键词
D O I
10.1016/S0735-1097(03)00623-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this paper is to examine the incidence and determinants of permanent complete heart block (CHB) after nonsurgical septal reduction therapy (NSRT), and to evaluate the clinical impact of permanent pacemaker (PPM) placement. BACKGROUND Nonsurgical septal reduction therapy with ethanol improves the clinical and hemodynamic parameters in patients with symptomatic hypertrophic obstructive cardiomyopathy. Complete heart block is a common complication after NSRT. METHODS The database of 261 consecutive patients who underwent NSRT at Baylor College of Medicine was reviewed. Clinical variables that were considered as possible determinants for CHB after NSRT were: age, gender, New York Heart Association (NYHA) functional class, left ventricular outflow tract (LVOT) gradient at rest or with provocation, septal thickness, and baseline exercise duration. For electrocardiographic (ECG) variables, the presence of first-degree atrioventricular (AV) block, bifascicular block, left bundle branch block, atrial fibrillation, and left ventricular hypertrophy were analyzed. In addition, the volume of ethanol injected, the method of administration of ethanol (i.e., bolus vs. slow injection [over 30 to 60 s]), number of septal arteries occluded, use of myocardial echocardiography, and infarct size as determined by peak creatine kinase level. RESULTS Of 261 consecutive patients, 37 had PPM or automatic implantable cardiac defibrillator placed before NSRT. Of the remaining 224 patients, 31 (14%) developed CHB after the procedure. Multivariate logistic regression analysis showed that female gender (odds ratio [OR] 4.3; p = 0.02), bolus injection of ethanol (OR 51; p = 0.004), injecting more than one septal artery (OR 4.6; p = 0.016), the presence of left bundle branch block (OR 39; p = 0.002), and first-degree AV block (OR 14; p = 0.001) on the baseline ECG are independent predictors of CHB after NSRT. Patients requiring PPM placement had a similar improvement in their NYHA functional class, septal thickness reduction, LVOT gradient reduction, and improvement of exercise capacity when compared with patients who did not require pacing. CONCLUSIONS Multiple demographic, electrocardiographic, and technical factors seem to increase the risk of CHB after NSRT. Patients with CHB after NSRT derive similar clinical and hemodynamic benefit to patients who did not require permanent pacing. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 50 条
  • [21] Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up
    Lakkis, NM
    Nagueh, SF
    Dunn, JK
    Killip, D
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) : 852 - 855
  • [22] Three-Dimensional Heart Printing for Planning of Septal Reduction Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy
    Veselka, Josef
    Adla, Theodor
    Adlova, Radka
    Bartel, Thomas
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2018, 27 (03) : 165 - 166
  • [23] Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy
    Chang, SM
    Sekandarzad, MW
    Jiang, S
    Nagueh, S
    Spencer, W
    Lakkis, N
    AMERICAN HEART JOURNAL, 2003, 146 (06) : 1112 - 1114
  • [24] Reoperation Was an Effective Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy After Septal Reduction Therapy
    Zhang, Yang
    Zhu, Changsheng
    Song, Changpeng
    Yin, Kunlun
    Zhang, Jian
    Huang, Manyun
    Zheng, Xinxin
    Lu, Jie
    Fang, Xiaonan
    Zhou, Zhou
    Wang Shuiyun
    Huang, Xiaohong
    CIRCULATION, 2021, 144
  • [25] Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    Desai, Milind Y.
    Owens, Anjali
    Geske, Jeffrey B.
    Wolski, Kathy
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Cremer, Paul C.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Li, Wanying
    Sterling, Lulu
    Lampl, Kathy
    Edelberg, Jay M.
    Sehnert, Amy J.
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) : 95 - 108
  • [26] The incidence of conduction system block after septal reduction in patients with hypertrophic obstructive cardiomyopathy
    Qin, JX
    Shiota, T
    Asher, CR
    Agler, DA
    Drinko, JK
    Smedira, NG
    Tuzcu, EM
    Lytle, BW
    Lever, HM
    CIRCULATION, 2002, 106 (19) : 655 - 655
  • [27] OUTCOMES OF PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY AND PULMONARY HYPERTENSION UNDERGOING SEPTAL REDUCTION THERAPY STRATIFIED BY TREATMENT MODALITY
    Isath, Ameesh
    Lanier, Gregg M.
    Spielvogel, David
    Malekan, Ramin
    Steinmetz, Carolyn
    Fishkin, Tzvi
    Semaan, Rosa
    Panza, Julio A.
    Naidu, Srihari S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 550 - 550
  • [28] Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy
    Dimitrow, PP
    Podolec, P
    Grodecki, J
    Plazak, W
    Dudek, D
    Pieniazek, P
    Bacior, B
    Legutko, J
    Olszowska, M
    Kostkiewicz, M
    Kawecka-Jaszcz, K
    Tracz, W
    Dubiel, JS
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 94 (01) : 31 - 34
  • [29] Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy
    Cheng, TO
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (07): : 982 - 982
  • [30] Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: Short-term results in 50 consecutive procedures
    Nielsen, CD
    Killip, D
    Spencer, WH
    CLINICAL CARDIOLOGY, 2003, 26 (06) : 275 - 279